SectorBiological Technology
Established Date--
Listing Date08/11/2016
ExchangeNASDAQ Stock Exchange
Full-time Employees5
Fiscal Year Ends31/12
Security TypeCommon stock
Office address2450 Holcombe Blvd, TMC Partners Office 1.311, Houston, Texas 77021
Business
IntroductionMarker Therapeutics, Inc., was originally incorporated under the laws of Nevada in 1991 and re-incorporated in Delaware in October 2018. The company is a clinical-stage immuno-oncology company developing novel T-cell immunotherapies using its multi-antigen recognition T-cell technology. Its method is designed to target a variety of tumor-associated antigens to treat hematological malignancies and solid tumors without the need for genetic modification.
